Home » VIRAGEN ANNOUNCES ASIAN EXPANSION WITH SOUTH KOREAN MULTIFERON MARKETING AGREEMENT
VIRAGEN ANNOUNCES ASIAN EXPANSION WITH SOUTH KOREAN MULTIFERON MARKETING AGREEMENT
Viragen, Inc. today announced that it has entered into a license agreement with
Kuhnil Pharm Co. Ltd., headquartered in Seoul, to distribute Multiferon(R) (multi-subtype,
natural human alpha interferon) in South Korea. While financial terms were not
disclosed, Viragen will receive a small up-front license fee in exchange for
providing exclusive marketing rights to the drug in South Korea for a period
of ten years.
PR
Newswire
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May